Cutter Capital Management as of Dec. 31, 2024
Portfolio Holdings for Cutter Capital Management
Cutter Capital Management holds 21 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | 9.2 | $22M | 32k | 712.33 | |
| Johnson & Johnson (JNJ) | 8.4 | $21M | 142k | 144.62 | |
| Royalty Pharma Shs Class A (RPRX) | 8.0 | $20M | 765k | 25.51 | |
| Abbvie (ABBV) | 7.4 | $18M | 102k | 177.70 | |
| Ultragenyx Pharmaceutical (RARE) | 7.0 | $17M | 407k | 42.07 | |
| Bridgebio Pharma (BBIO) | 6.3 | $15M | 560k | 27.44 | |
| Sarepta Therapeutics (SRPT) | 6.2 | $15M | 124k | 121.59 | |
| Insmed Com Par $.01 (INSM) | 6.0 | $15M | 211k | 69.04 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.3 | $13M | 585k | 22.04 | |
| Miragen Therapeutics (VRDN) | 4.9 | $12M | 629k | 19.17 | |
| Amgen (AMGN) | 4.1 | $9.9M | 38k | 260.64 | |
| Agios Pharmaceuticals (AGIO) | 4.1 | $9.9M | 302k | 32.86 | |
| Vera Therapeutics Cl A (VERA) | 3.7 | $9.0M | 213k | 42.29 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 3.6 | $8.7M | 337k | 25.70 | |
| Moderna (MRNA) | 3.4 | $8.2M | 198k | 41.58 | |
| Perrigo SHS (PRGO) | 3.1 | $7.6M | 295k | 25.71 | |
| Janux Therapeutics (JANX) | 2.6 | $6.4M | 120k | 53.54 | |
| Akero Therapeutics (AKRO) | 2.6 | $6.4M | 230k | 27.82 | |
| Tarsus Pharmaceuticals (TARS) | 2.6 | $6.2M | 113k | 55.37 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.0 | $2.5M | 147k | 16.75 | |
| Neumora Therapeutics (NMRA) | 0.7 | $1.6M | 150k | 10.60 |
